Published in BMC Cancer on March 27, 2007
Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia (2010) 3.93
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
A pathway-based classification of human breast cancer. Proc Natl Acad Sci U S A (2010) 3.30
Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis (2008) 2.86
Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nat Cell Biol (2012) 2.46
LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat Med (2012) 2.24
Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res (2011) 2.15
Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev (2012) 1.96
Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat (2009) 1.83
Mutation patterns in cancer genomes. Proc Natl Acad Sci U S A (2009) 1.69
Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate. Expert Opin Ther Targets (2010) 1.62
Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res (2009) 1.55
Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis. Mol Biol Cell (2011) 1.54
Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes. Bioinformatics (2008) 1.49
A functional Notch-survivin gene signature in basal breast cancer. Breast Cancer Res (2008) 1.46
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene (2008) 1.44
Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13. Breast Cancer Res (2014) 1.41
Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer. PLoS One (2015) 1.40
Retracted Gene-gene interaction network analysis of ovarian cancer using TCGA data. J Ovarian Res (2013) 1.40
MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors. Blood (2014) 1.32
TGF-β signaling in breast cancer cell invasion and bone metastasis. J Mammary Gland Biol Neoplasia (2011) 1.28
Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples. Nat Protoc (2009) 1.27
Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma. BMC Syst Biol (2010) 1.26
A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells. J Transl Med (2013) 1.25
Protein kinase D as a potential new target for cancer therapy. Biochim Biophys Acta (2010) 1.25
Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons. Proc Natl Acad Sci U S A (2012) 1.19
Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. J Lipid Res (2008) 1.19
Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2. PLoS One (2011) 1.18
Concern DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation. J Biol Chem (2011) 1.18
Investigating the efficacy of nonlinear dimensionality reduction schemes in classifying gene and protein expression studies. IEEE/ACM Trans Comput Biol Bioinform (2008) 1.18
Frizzled7 as an emerging target for cancer therapy. Cell Signal (2011) 1.16
Elevated expression of squamous cell carcinoma antigen (SCCA) is associated with human breast carcinoma. PLoS One (2011) 1.13
The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. Cancer Cell Int (2014) 1.11
Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics. Breast Cancer Res (2015) 1.08
Bimodal gene expression patterns in breast cancer. BMC Genomics (2010) 1.07
In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Mol Cell Proteomics (2010) 1.03
DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin. Mol Biol Cell (2011) 1.00
Confounding effects in "A six-gene signature predicting breast cancer lung metastasis". Cancer Res (2009) 0.99
Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study. BMC Cancer (2010) 0.99
Molecular profiling of multiple human cancers defines an inflammatory cancer-associated molecular pattern and uncovers KPNA2 as a uniform poor prognostic cancer marker. PLoS One (2013) 0.98
Diverse roles for the paxillin family of proteins in cancer. Genes Cancer (2012) 0.98
Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation. PLoS One (2011) 0.97
The p53 target Wig-1: a regulator of mRNA stability and stem cell fate? Cell Death Differ (2011) 0.96
Ion channels expression and function are strongly modified in solid tumors and vascular malformations. J Transl Med (2016) 0.96
N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration. J Biol Chem (2013) 0.96
Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. Oncotarget (2014) 0.95
AMP-Activated Protein Kinase α 2 Isoform Suppression in Primary Breast Cancer Alters AMPK Growth Control and Apoptotic Signaling. Genes Cancer (2013) 0.94
NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas. Am J Pathol (2011) 0.94
The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12. J Biol Chem (2010) 0.93
Cisplatin induces differentiation of breast cancer cells. Front Oncol (2013) 0.92
Molecular characterization of the tumor-suppressive function of nischarin in breast cancer. J Natl Cancer Inst (2011) 0.92
Invoking the power of thrombospondins: regulation of thrombospondins expression. Matrix Biol (2014) 0.92
Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features. Breast Cancer Res Treat (2012) 0.91
Collagen alpha1(XI) in normal and malignant breast tissue. Mod Pathol (2008) 0.89
Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers. Int J Cancer (2009) 0.89
A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma. Mol Cell Biol (2013) 0.89
Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility. Int J Oncol (2014) 0.88
Cytochrome b5 reductase 2 is a novel candidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma. Tumour Biol (2013) 0.87
Cooperative interaction between the MUC1-C oncoprotein and the Rab31 GTPase in estrogen receptor-positive breast cancer cells. PLoS One (2012) 0.87
Comparison of breast cancer to healthy control tissue discovers novel markers with potential for prognosis and early detection. PLoS One (2010) 0.87
In vitro three-dimensional modeling of fallopian tube secretory epithelial cells. BMC Cell Biol (2013) 0.87
MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway. Oncotarget (2015) 0.87
A resampling-based meta-analysis for detection of differential gene expression in breast cancer. BMC Cancer (2008) 0.86
ASPN and GJB2 Are Implicated in the Mechanisms of Invasion of Ductal Breast Carcinomas. J Cancer (2012) 0.86
Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer. Breast Cancer Res Treat (2015) 0.85
Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies. Oncotarget (2014) 0.85
RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis. Cancer Res (2012) 0.85
Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer. Int J Mol Sci (2011) 0.84
Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer. Virchows Arch (2013) 0.84
A method for visualization of "omic" datasets for sphingolipid metabolism to predict potentially interesting differences. J Lipid Res (2011) 0.84
A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers. PLoS One (2014) 0.84
Increased levels of active c-Src distinguish invasive from in situ lobular lesions. Breast Cancer Res (2009) 0.84
Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype. Breast Cancer Res Treat (2013) 0.84
Evaluation of malignancy-risk gene signature in breast cancer patients. Breast Cancer Res Treat (2009) 0.84
Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. J Pathol Clin Res (2014) 0.83
Human CST abundance determines recovery from diverse forms of DNA damage and replication stress. Cell Cycle (2014) 0.83
Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression. Oncotarget (2016) 0.83
Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients. PLoS One (2015) 0.82
Grading breast cancer tissues using molecular portraits. Mol Cell Proteomics (2013) 0.82
Dichotomous roles for the orphan nuclear receptor NURR1 in breast cancer. BMC Cancer (2013) 0.81
Prestige centrality-based functional outlier detection in gene expression analysis. Bioinformatics (2009) 0.81
Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12. PLoS One (2014) 0.81
Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer. Clin Proteomics (2012) 0.80
Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance. Virchows Arch (2011) 0.80
Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis. Chin J Cancer (2015) 0.80
Estimating developmental states of tumors and normal tissues using a linear time-ordered model. BMC Bioinformatics (2011) 0.80
Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment. Oncotarget (2015) 0.80
The cell surface mucin podocalyxin regulates collective breast tumor budding. Breast Cancer Res (2016) 0.80
Disease progression and solid tumor survival: a transcriptome decoherence model. Mol Cell Probes (2009) 0.79
Detection of collagen triple helix repeat containing-1 and nuclear factor (erythroid-derived 2)-like 3 in colorectal cancer. BMC Clin Pathol (2012) 0.79
Identification of breast cancer prognosis markers using integrative sparse boosting. Methods Inf Med (2012) 0.79
Cancer Cell Invasion in Three-dimensional Collagen Is Regulated Differentially by Gα13 Protein and Discoidin Domain Receptor 1-Par3 Protein Signaling. J Biol Chem (2015) 0.79
The numbers of FoxP3+ lymphocytes in sentinel lymph nodes of breast cancer patients correlate with primary tumor size but not nodal status. Cancer Invest (2011) 0.79
Association of HADHA expression with the risk of breast cancer: targeted subset analysis and meta-analysis of microarray data. BMC Res Notes (2012) 0.78
Alternative mRNA splicing generates two distinct ADAM12 prodomain variants. PLoS One (2013) 0.78
Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells. Mol Endocrinol (2013) 0.78
The dual role of asporin in breast cancer progression. Oncotarget (2016) 0.77
Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samples. PLoS One (2011) 0.77
Expression of YY1 correlates with progression and metastasis in esophageal squamous cell carcinomas. Onco Targets Ther (2014) 0.77
Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGFβ receptor I kinase. J Pathol (2015) 0.77
Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (1995) 88.48
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74
Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer (2002) 34.99
Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A (2003) 34.68
Gene-expression profiles in hereditary breast cancer. N Engl J Med (2001) 29.80
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A (1999) 14.16
Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A (2003) 13.00
Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest (2003) 12.56
Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature (2003) 12.54
Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol (2003) 11.12
Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett (2004) 11.00
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell (2003) 7.93
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell (2000) 5.72
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell (2002) 5.23
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol (2002) 5.20
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest (2004) 5.06
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene (1999) 3.95
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res (2004) 3.90
Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol Cell Biol (1996) 3.76
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell (2004) 3.73
Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol (2004) 3.64
The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res (2003) 3.58
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47
The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene (2005) 3.42
An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat Genet (2005) 3.00
QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol (2003) 2.88
The Wnt/Wg signal transducer beta-catenin controls fibronectin expression. Mol Cell Biol (1999) 2.68
Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer. Breast Cancer Res (2005) 2.43
Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res (2006) 2.36
Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer (1994) 2.06
Tumor formation dependent on proteoglycan biosynthesis. Science (1988) 2.04
Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res (2006) 2.03
Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. J Mol Diagn (2003) 1.99
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol (2004) 1.95
Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res (2002) 1.93
Molecular alterations in primary prostate cancer after androgen ablation therapy. Clin Cancer Res (2005) 1.88
Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res (2004) 1.83
Expression profiling predicts outcome in breast cancer. Breast Cancer Res (2002) 1.81
beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene (2004) 1.79
Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res (2003) 1.71
Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin Cancer Res (2006) 1.57
Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer (1997) 1.46
Evaluation of procedures for amplification of small-size samples for hybridization on microarrays. Genomics (2004) 1.44
Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene (2004) 1.39
Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. Invest Ophthalmol Vis Sci (2004) 1.35
cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells. Oncogene (2003) 1.34
Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family. J Biol Chem (2001) 1.33
A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol (2002) 1.33
A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells. Biochem Biophys Res Commun (2003) 1.33
Polymorphism in signal transduction is a major route through which osteoarthritis susceptibility is acting. Curr Opin Rheumatol (2005) 1.29
Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. J Cell Sci (2001) 1.29
Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR. Breast Cancer Res Treat (2002) 1.26
Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. Int J Oncol (2004) 1.20
Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. Exp Mol Pathol (2003) 1.18
A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg (1998) 1.17
Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1). Gene Expr Patterns (2006) 1.16
Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer. Cancer Res (2003) 1.16
Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways. Oncogene (2006) 1.15
Altered expression of E-cadherin in breast cancer. patterns, mechanisms and clinical significance. Eur J Cancer (2000) 1.14
Tissue microarrays for miniaturized high-throughput molecular profiling of tumors. Exp Hematol (2002) 1.11
Disulfide bond assignments of secreted Frizzled-related protein-1 provide insights about Frizzled homology and netrin modules. J Biol Chem (2001) 1.10
Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin. Biochem J (2002) 1.08
Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer (1999) 1.04
Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion. Int J Cancer (2003) 1.03
Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer. Oncogene (2003) 1.02
Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast (2004) 1.01
Identification of genes preferentially expressed in periodontal ligament: specific expression of a novel secreted protein, FDC-SP. Biochem Biophys Res Commun (2005) 0.98
Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion. FASEB J (2003) 0.97
Cross-regulation of Wnt signaling and cell adhesion. Differentiation (2004) 0.95
Prognosis of breast cancer and gene expression profiling using DNA arrays. Ann N Y Acad Sci (2002) 0.93
A method for gene expression analysis by oligonucleotide arrays from minute biological materials. Anal Biochem (2004) 0.93
Breast cancer revisited using DNA array-based gene expression profiling. Int J Cancer (2003) 0.93
Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol (2003) 0.92
Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer. Hum Pathol (2004) 0.86
cDNA cloning, genomic structure, and chromosome mapping of the human epithelial membrane protein CL-20 gene (EMP1), a member of the PMP22 family. Genomics (1997) 0.85
Molecular profiles of invasive mucinous and ductal carcinomas of the breast: a molecular case study. Cancer Genet Cytogenet (2003) 0.84
The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res (2005) 2.79
Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med (2005) 2.60
Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation. Gynecol Oncol (2011) 2.57
Choroidal vessel diameter in central serous chorioretinopathy. Acta Ophthalmol (2013) 2.16
siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol (2009) 1.86
Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst (2002) 1.77
The role of electrostatics in protein-membrane interactions. Biochim Biophys Acta (2006) 1.76
Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat Prod Rep (2006) 1.70
Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology (2006) 1.57
Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment. Cell Cycle (2012) 1.50
Aurora kinase inhibitors: progress towards the clinic. Invest New Drugs (2012) 1.44
Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod (2008) 1.40
Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines. Mol Cancer Ther (2011) 1.39
The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res (2009) 1.39
Aggressive angiomyxoma of the scrotum mimicking huge hydrocele: case report and literature review. Case Rep Med (2009) 1.35
Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Blood (2007) 1.32
Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay. Cell Cycle (2008) 1.31
Biocatalytic induction of supramolecular order. Nat Chem (2010) 1.30
Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. Am J Pathol (2008) 1.29
MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci (2011) 1.28
A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog (2011) 1.26
Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study. J Cancer Res Clin Oncol (2008) 1.21
CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol Cancer Res (2009) 1.15
MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas. J Neurooncol (2013) 1.14
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest (2012) 1.12
Human paralogs of KIAA0187 were created through independent pericentromeric-directed and chromosome-specific duplication mechanisms. Genome Res (2002) 1.10
Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. Am J Respir Cell Mol Biol (2007) 1.09
Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population. J Cell Mol Med (2009) 1.07
Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy. Invest Ophthalmol Vis Sci (2013) 1.07
Scrotal epidermal inclusion cyst clinically mimicking polyorchidism in a child: ultrasonic characteristics. Pediatr Radiol (2003) 1.06
The West Midlands Bladder Cancer Prognosis Programme: rationale and design. BJU Int (2009) 1.06
Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. Neoplasia (2007) 1.05
Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals. Diagn Pathol (2011) 1.04
A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas. J Exp Clin Cancer Res (2012) 1.04
Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Blood (2005) 1.04
Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma. J Virol (2011) 1.04
The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2. J Virol (2002) 1.03
MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications. J Cell Mol Med (2011) 1.02
4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. J Med Chem (2006) 1.02
The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol (2015) 1.02
Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2010) 1.01
Immunohistochemical analysis of the biological potential of odontogenic keratocysts. J Oral Pathol Med (2006) 1.01
Oncogenic human papillomavirus imposes an instructive pattern of DNA methylation changes which parallel the natural history of cervical HPV infection in young women. Carcinogenesis (2012) 1.01
TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40. J Virol (2003) 1.00
Repair of an isolated huge congenital left ventricular diverticulum. J Thorac Cardiovasc Surg (2004) 0.98
Counterintuitive kinetics in Tsuji-Trost allylation: ion-pair partitioning and implications for asymmetric catalysis. J Am Chem Soc (2008) 0.98
Proteomic profiling of urine for the detection of colon cancer. Proteome Sci (2008) 0.97
The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma. J Pathol (2009) 0.97
Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study. J Clin Pathol (2011) 0.97
The Newman-Kwart rearrangement of O-aryl thiocarbamates: substantial reduction in reaction temperatures through palladium catalysis. Angew Chem Int Ed Engl (2009) 0.97
Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide. Am J Respir Cell Mol Biol (2008) 0.97
A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels. PLoS One (2012) 0.97
Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril (2006) 0.97
The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines. J Pharmacol Exp Ther (2004) 0.96
Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma. J Pathol (2011) 0.95
Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas. Epigenetics (2007) 0.95
Triterpenoid pyrazines and benzopyrazines with cytotoxic activity. J Nat Prod (2007) 0.95
The diagnostic role of claudins in serous effusions. Am J Clin Pathol (2007) 0.95
DNA methylation profiles of long- and short-term glioblastoma survivors. Epigenetics (2013) 0.94
JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes. Biochem Pharmacol (2007) 0.94
Dumbbell-shaped peripheral primitive neuroectodermal tumor of the spine--case report and review of the literature. J Neurooncol (2008) 0.93
Aurora kinases: structure, functions and their association with cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2008) 0.93
Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2. Neoplasia (2011) 0.93
Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells. Blood (2006) 0.93
Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells. Anticancer Res (2006) 0.92
Synthesis of A-seco derivatives of betulinic acid with cytotoxic activity. J Nat Prod (2004) 0.91
Assessment of novel combinations of biomarkers for the detection of colorectal cancer. Cancer Biomark (2010) 0.91
The miRNA expression profile of the uveal melanoma. Sci China Life Sci (2011) 0.91
Wnt signaling in prostate development and carcinogenesis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2011) 0.90
Differentiation of tumours of ductal and lobular origin: II. Genomics of invasive ductal and lobular breast carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2005) 0.90
Thoracoscopic treatment of benign esophageal tumors. Wideochir Inne Tech Maloinwazyjne (2012) 0.90
Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells. J Pathol (2013) 0.89
Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature. J Virol (2012) 0.89
Intramedullary spinal cord and cauda equina metastasis of breast carcinoma: case report. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2010) 0.89
Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis. Am J Pathol (2010) 0.88
Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes. J Gen Virol (2008) 0.88
Synthesis of phthalates of betulinic acid and betulin with cytotoxic activity. Bioorg Med Chem (2005) 0.87
Squamous cell carcinoma of the oral cavity rarely harbours oncogenic human papillomavirus. Oral Oncol (2011) 0.87
Therapeutic targeting the loss of the birt-hogg-dube suppressor gene. Mol Cancer Ther (2011) 0.87
Role of sexual behavior in the acquisition of asymptomatic Epstein-Barr virus infection: a longitudinal study. Pediatr Infect Dis J (2005) 0.86
Lapatinib in breast cancer - the predictive significance of HER1 (EGFR), HER2, PTEN and PIK3CA genes and lapatinib plasma level assessment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2010) 0.86